4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-020068
Chief Medical Officer sold 1,000 shares at $25.01 ($25,010)
- Chief Medical Officer acquired 500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-03-14 | Sale | −500 | $25.01 | $12,505 | 142,115 | I |
| Ho Carole Chief Medical Officer | 2019-03-14 | Option exercise | +500 | $5.28 | $2,640 | 500 | D |
| Ho Carole Chief Medical Officer | 2019-03-14 | Sale | −500 | $25.01 | $12,505 | 0 | D |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-03-14 | Option exercise · Stock Option (right to buy) | −500 | 111,630 | D | ||
| Open-market sales · 1,000 sh · avg $25.01 · $25,010 | |||||||
Loading xslF345X03/doc4.xml…